ZYZongke Yang

Zongke Yang

*This is an algorithmically generated author record based on publicly available information.

Zongke Yang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ALG13 as a prognostic biomarker of prostate cancer associated with tumor immune infiltration and mediated by upstream ncRNA

    by Maolin Xiao, Yunfeng Xiao, Wanlan Liu, Xiao Xiao, Zongke Yang

    Asparagine-linked glycosylation 13 (ALG13) is a highly conserved protein in most eukaryotes, which belongs to the OTU family. It plays a role in neuroblastoma and non-small cell lung cancer. However, the role of ALG13 in prostate cancer (Pca) and its correlation with tumor-infiltrating immune cells remain unclear. Thus, in this study, we extracted and analyzed The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), Tumor Immune Estimation Resource (TIMER), and Human Protein Atlas (HPA) data sets to study the potential carcinogenic mechanism of ALG13, including ALG13 expression, prognosis and the correlation of ALG13 expression in immune cell infiltration in Pca. Furthermore, the potential biological signaling pathway of ALG13 in Pca was studied by using Gene set enrichment analysis (GSEA). Upstream microRNA and lncRNA related to ALG13 were found through the prediction of miRWalk and starBase. Results showed that ALG13 was highly expressed in Pca tissues and associated with poor overall survival (OS) and disease-specific survival (DSS). ALG13 expression was correlated with immune cell infiltration. In addition, ALG13 was co-expressed with most immune-related genes, and the high-expression of ALG13 was effective for immune-checkpoint blockade treatment. ALG13 may regulate the pathogenesis of Pca through tumor and immune-related pathways. Finally, AL390728.6/hsa-miR-381-3p axis is considered as a potential upstream ncRNA-related pathway of ALG13 in Pca. Our results demonstrate that the ncRNA-mediated upregulation of ALG13 is associated with poor OS in Prostate adenocarcinoma (PRAD) and tumor immune infiltration. ALG13 may be a new potential prognostic biomarker.


  • Open Access

    Expression and Role of TRIM2 in Human Diseases

    by Maolin Xiao, Jianjun Li, Qingyuan Liu, Xiangbiao He, Zongke Yang, Delin Wang

    Tripartite motif (TRIM) protein family proteins contain more than 80 members in humans, and most of these proteins exhibit E3 ubiquitin ligase activity mediated through a RING finger domain. Their biological functions are very complex, and they perform diverse functions in cell evolution processes, such as intracellular signaling, development, apoptosis, protein quality control, innate immunity, autophagy, and carcinogenesis. Tripartite motif‐containing protein 2 (TRIM2), a member of the TRIM superfamily, is an 81 kDa multidomain protein, also known as CMT2R or RNF86, located at 4q31.3. TRIM2 functions as an E3 ubiquitin ligase. Current studies have shown that TRIM2 can play roles in neuroprotection, neuronal rapid ischemic tolerance, antiviral responses, neurological diseases, etc. Moreover, based on some studies in tumors, TRIM2 regulates tumor proliferation, migration, invasion, apoptosis, and drug resistance through different mechanisms and plays a critical role in tumor occurrence and development. This review is aimed at providing a systematic and comprehensive summary of research on TRIM2 and at exploring the potential role of TRIM2 as a biomarker and therapeutic target in many kinds of human diseases.